Navigation Links
Orange corn holds promise for reducing blindness, child death

WEST LAFAYETTE, Ind. - Decreasing or increasing the function of a newly discovered gene in corn may increase vitamin A content and have significant implications for reducing childhood blindness and mortality rates, according to a Purdue University-led study.

Torbert Rocheford, the Patterson Endowed Chair of Translational Genomics and professor of agronomy at Purdue, led the study that made findings in yellow and particularly orange corn, a type he said likely originated in the Caribbean and is popular in some Asian and South American countries as well as in northern Italy. The orange color comes from relatively higher levels of carotenoids, one of which is beta-carotene. Humans convert beta-carotene, which also is abundant in carrots, into vitamin A during digestion.

Rocheford is using simple visual selection for darker orange color combined with more advanced molecular natural diversity screening techniques to create better lines of the orange corn.

"We're sort of turbocharging corn with desirable natural variation to make it darker and more nutritious," Rocheford said.

Between 250,000 and 500,000 children mostly in Africa and Southeast Asia - go blind each year because of vitamin A deficiency, according to the World Health Organization. Half of those children will die within a year of going blind. Rocheford said increasing beta-carotene levels in cereal grains, such as corn, is an economical approach to addressing these deficiencies in developing countries.

Rocheford said the gene beta-carotene hydroxylase 1 (crtR-B1) alters beta-carotene in corn in a way that reduces pro-vitamin A activity. Through a process known as hydroxylation, beta-carotene is converted into other carotenoids that can cut the amount of pro-vitamin A that is created through digestion in half, or eliminate it altogether. Reducing the function of the crtR-B1 gene would reduce hydroxylation considerably.

"Because of this, selecting a form of the gene that does not have much activity causes beta-carotene to build up," said Rocheford, whose findings were published in the journal Nature Genetics. "We're have started to move the favorable 'weak' allele into breeding materials."

Conversely, "strong alleles" increasing crtR-B1 function boost the hydroxylation process, which creates more zeaxanthin. Zeaxanthin is a micronutrient that could protect against macular degeneration, the leading cause of blindness in people over 55 in Western industrialized nations, according to the American Macular Degeneration Foundation.

Zeaxanthin makes up 75 percent of the central macula in human eyes, according to the AMDF, and data show that macular pigment increases through dietary supplements.

Rocheford said the findings are encouraging for addressing problems in both developed and developing nations.

"It's like a designer gene. We can select one version for the U.S. population to increase zeaxanthin and a different version to increase beta-carotene for the needs of the developing world," he said.

Rocheford's research will continue to look for ways to improve the nutrient profile of orange corn through simple visual selection and more advanced DNA and compound analyses. He said further efforts would focus on other genes that also hold promise to increase pro-vitamin A in corn.

Another challenge, he admits, would be introducing a new variety of corn to consumers.

"The U.S. only grows yellow and white corn, and Africa largely grows white corn," Rocheford said. "But parts of the world some parts of Asia and South America actually prefer orange corn."

Rocheford recently returned from a meeting in Zambia and saw an initial indication of consumer acceptance of orange corn there. He also stopped in northern Italy where orange corn is used for polenta, a sign that acceptance is possible in the developed world as well.


Contact: Brian Wallheimer
Purdue University

Related biology news :

1. Introducing Orange Bulldog
2. Bitter orange SRMs: Tools for product analysis/quality
3. Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
4. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
5. Agent Orange exposure increases veterans risk of aggressive recurrence of prostate cancer
6. Orange peels, newspapers may lead to cheaper, cleaner ethanol fuel
7. Chlamy genome holds clues for renewable energy, the environment and human health
8. Stanfords nanowire battery holds 10 times the charge of existing ones
9. Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms
10. Craniosynostosis minimally invasive surgery holds more promise than old procedure
11. Cow stomach holds key to turning corn into biofuel
Post Your Comments:
Related Image:
Orange corn holds promise for reducing blindness, child death
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology: